SEC Company Response from BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Aug 31, 2017
BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: Aug. 31, 2017 · CIK: 0000925741 · Accession: 0001437749-17-015464
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218124
Letter
Re:
bcda20170830_corresp.htm
August 31, 2017
VIA EDGAR
Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Attention:
Russell Mancuso, Branch Chief, Office of Electronics and Machinery Brian Cascio, Accounting Branch Chief Julie Sherman Tom Jones
BioCardia, Inc.
Registration Statement on Form S-3
Originally Filed on May 19, 2017
File No. 333-218124
Acceleration Request
Requested Date: September 1, 2017 Requested Time: 2:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-218124) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Lance E. Brady at (650) 565-3836 or emailing him at lbrady@wsgr.com.
In connection with the acceleration request, the Company hereby acknowledges that:
●
should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
●
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
●
the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
BioCardia, Inc.
Show Raw Text
CORRESP 1 filename1.htm bcda20170830_corresp.htm August 31, 2017 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Russell Mancuso, Branch Chief, Office of Electronics and Machinery Brian Cascio, Accounting Branch Chief Julie Sherman Tom Jones Re: BioCardia, Inc. Registration Statement on Form S-3 Originally Filed on May 19, 2017 File No. 333-218124 Acceleration Request Requested Date: September 1, 2017 Requested Time: 2:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-218124) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Lance E. Brady at (650) 565-3836 or emailing him at lbrady@wsgr.com. In connection with the acceleration request, the Company hereby acknowledges that: ● should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; ● the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and ● the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, BioCardia, Inc. /s/ David McClung David McClung Vice President of Finance cc: Peter Altman, President and Chief Executive Officer Michael J. Danaher, Wilson Sonsini Goodrich & Rosati, P.C. Lance E. Brady, Wilson Sonsini Goodrich & Rosati, P.C.